ACE inhibitors and ARBs may improve clinical outcomes in patients with heart failure with preserved ejection fraction.
Absolute Event Rate: 0% vs 0%
= 0%, P = 0.074). These data suggest that ACE-I and ARBs may have a role in improving outcomes of patients with HFpEF, underscoring the need for future research with careful patient selection, and trial design and conduct.
Khan et al. (Mon,) reported a other. ACE inhibitors and ARBs may improve clinical outcomes in patients with heart failure with preserved ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: